The Hypotensive Effect of Metformin in Hypertensive Patients.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02072382|
Recruitment Status : Unknown
Verified August 2015 by Hospital de Clinicas de Porto Alegre.
Recruitment status was: Recruiting
First Posted : February 26, 2014
Last Update Posted : August 27, 2015
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Drug: Metformin Drug: Placebo||Phase 4|
The primary outcome was the difference in mean 24-hour blood pressure variation between the two groups after the intervention. The difference in mean of blood pressure during daytime and nighttime in 24h ambulatory blood pressure monitory, as well as the office BP and laboratory differences were considered secondary outcomes.
This randomized, double-blind parallel study was conducted in the Hypertension Clinic of the Department of Cardiology, Hospital de Clínicas de Porto Alegre (Porto Alegre, Brazil).
We selected hypertensive individuals (controlled or not) without diabetes aged 18-70 years.
Exclusion criteria: metformin intolerance, creatinine > 1,5 mg/dl Risks: adverse effects related to metformin use, mainly diarrhea and nausea Benefits: possible lower effect on arterial pressure Statistical analysis: sample size was calculated on the basis of a standard deviation of 8 mm Hg and effect size of 5 mm Hg in 24-h systolic ABPM and a two-sided significance level of 5%. A sample size of 42 patients per group was estimated to provide a power of 80% to reject the null hypothesis. Considering possible 10% of losses, the final calculated sample was 92 patients.
The baseline comparison between groups was performed using the Student t test for continuous variables and x2 for categorical variables. In each group, the change in BP by ABPM -24 h, daytime and nighttime, and laboratory tests was calculated by subtracting baseline values measured after the intervention period. The difference between groups was calculated by subtracting the variation observed between them (δ-values). The differences in BP variation and laboratory tests were analyzed by analysis of variance for repeated measures (MANOVA). For differences in pressure variation adjustment was considered for the baseline BP values (analysis of covariance). All tests were two-tailed and significance level was 5%. Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 13.0.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||92 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||The Hypotensive Effect of Simvastatin in Hypertensive Patients: a Placebo-controlled Randomized Clinical Trial With 24-h Ambulatory Blood Pressure Monitoring|
|Study Start Date :||May 2013|
|Actual Primary Completion Date :||August 2015|
|Estimated Study Completion Date :||December 2015|
Metformin 850 mg twice a day for eight weeks versus Placebo
metformin 850mg twice a day for eight weeks
Other Name: Glucophage
- The effect of metformin on blood pressure [ Time Frame: eight weeks ]The primary outcome was the difference in mean 24-hour BP variation between the two groups (metformin versus placebo) after the intervention.
- The difference in mean of BP during daytime and nighttime in ABPM-24h, as well as the office BP and laboratory differences were considered secondary outcomes. [ Time Frame: eight weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02072382
|Hospital de Clínicas de Porto Alegre||Recruiting|
|Porto Alegre, RS, Brazil|
|Contact: Corrêa Junior Vicente (51)99839395 firstname.lastname@example.org|
|Sub-Investigator: Correa Junior Vicente|
|Study Chair:||Gus Miguel||Hospital de Clínicas de Porto Alegre|